Pular para o conteúdo

Red Drop’s Bet on Pain-Free Blood Collection and the Next Wave of Diagnostics

28 de julho de 2026 · 38 min

Notas do episódio

In this episode of Diagnosing Dx, David Filby is joined by Thomas Briggs, Chief Growth Officer at RedDrop Dx.

Thomas brings more than 25 years of diagnostics and healthcare growth experience, spanning pharma, big diagnostics, medtech, and startup environments. In this conversation, we explore one of the most overlooked parts of diagnostics: blood collection, and why the process still looks far too similar to what it did decades ago.

Thomas breaks down where arm-based micro-sampling could genuinely change patient experience, from paediatrics and neurodivergent patients to home testing, clinical trials, and difficult vein access.

We also get into the commercial reality behind a product like this: where the most promising markets are, why education still matters, how labs and platforms need to adapt, and what it takes to build a medtech business without following the usual VC-heavy playbook.

This is a practical conversation about workflow, access, patient experience, and what happens when a simple shift in blood collection could unlock broader changes across diagnostics and healthcare delivery.

Key takeaways:
🔹 Why blood collection remains one of the least-innovated parts of diagnostics
🔹 Where arm-based micro-sampling could have the biggest clinical and commercial impact
🔹 Why paediatrics, neurodivergent patients, and difficult vein access are such important use cases
🔹 How home sampling could change clinical trials, routine monitoring, and direct-to-consumer care
🔹 What it takes to commercialise a medtech product in both consumer and managed-care settings

Chapters:
01:51 Thomas Briggs’ background in diagnostics, pharma, and medtech
06:28 Moving from big corporates into startups
11:04 What RedDrop Dx is building and how the device works
14:39 Where the biggest commercial opportunities are for arm-based micro-sampling
18:48 Why education and awareness are still a major challenge
21:22 RedDrop Dx’s story so far and why it was bootstrapped
26:05 How the company is building for growth across different market segments
30:10 Future milestones, home collection clearance, and expansion into Europe
31:31 Thomas’s outlook on diagnostics, home testing, and micro-sampling in 2026

Guest: Thomas Briggs
Chief Growth Officer at RedDrop Dx
LinkedIn: https://www.linkedin.com/in/thomas-briggs-959865177/

Host: David Filby
Founder and CEO of Elevra Consulting
LinkedIn: https://www.linkedin.com/in/davidfilby/

🔔 Subscribe to Diagnosing Dx for weekly conversations with leaders shaping the future of diagnostics and omics.

Todos os episódios de Diagnosing Dx

Configurações

Exibição

Idioma

Define quais estações você vê primeiro na página inicial.

Histórico

As rádios e episódios ouvidos recentemente e suas últimas buscas ficam só neste navegador.

Avisos

Um aviso rápido quando um podcast que você segue tem um episódio novo. Desative podcasts individuais pelo sino na página deles.

Conta

Salve favoritos – no app e no site.

Atalhos de teclado

/
Abrir busca
Espaço
Reproduzir ou pausar
← →
No player: voltar 15 s, avançar 30 s (episódios) · na fileira: próximo bloco
↑ ↓
Na fileira: alvo dentro do bloco
Home / End
Na fileira: primeiro ou último bloco
Esc
Fechar janela ou menu
?
Esta visão geral
Tocando agora

Ir para a estação

A seguir

    Adicione episódios com “A seguir” – eles tocam depois do episódio atual.